Mark Cuban Cost Plus Drugs

Mark Cuban Cost Plus Drugs is a transparent-pricing online pharmacy founded by Mark Cuban that aims to make prescription medications dramatically more affordable by publishing its cost-plus markup model directly to consumers. It sells generic and some brand-name drugs at prices meant to undercut traditional pharmacy middlemen. In WellRank's latest index it ranks tenth in GLP-1 weight loss AI answers with 8% visibility, appearing in largely positive mentions alongside brands like Novo Nordisk, GoodRx, and Hims & Hers.

Cost Plus Drugs, formally known as Mark Cuban Cost Plus Drug Company, operates as an online pharmacy and drug manufacturer focused on price transparency. It is headquartered in Dallas, Texas, and was co-founded by Mark Cuban. The business model strips out pharmacy benefit manager markups by charging a fixed percentage above its own cost for each drug, publishing that breakdown openly on its website at costplusdrugs.com.

• Transparent cost-plus pricing showing ingredient cost, markup, and pharmacy labor fee for each drug
• Generic prescription medications across a wide range of therapeutic categories
• A growing catalog that has expanded into some brand-name and specialty medications
• An in-house drug manufacturing operation intended to further reduce supply-chain costs
• Telehealth prescription pathway partnerships that allow patients to obtain prescriptions and fill them on the platform

The company primarily serves US consumers who are uninsured, underinsured, or simply paying high out-of-pocket costs for maintenance medications. It covers a broad range of conditions including diabetes, cardiovascular disease, mental health, and infectious disease. Interest in GLP-1 weight-loss drugs has brought a newer cohort of patients seeking affordable obesity treatment options to the platform.

• A middle-income patient without employer drug coverage who needs a long-term generic medication and wants to avoid insurance complexity.
• A price-savvy consumer who cross-shops pharmacy costs and uses tools like GoodRx before settling on the lowest option.
• A person with diabetes or obesity researching affordable access to medications such as metformin or GLP-1 adjacent generics.
• A caregiver managing prescriptions for a family member on a fixed income who prioritizes predictable, low monthly drug costs.

Cost Plus Drugs is a privately held company. Specific funding rounds and valuations are not publicly disclosed at a level that can be cited with confidence, though Mark Cuban has publicly acknowledged personal investment in the venture.

The company has publicly moved toward in-house drug manufacturing to gain more control over pricing and supply chains, a direction widely covered in business press. It has also expanded its drug catalog beyond its original generic-only focus and has drawn attention for its stated interest in making GLP-1 related medications more accessible as demand for weight-loss drugs has surged, as covered in broader telehealth reporting.

WellRank's corpus shows two positive and one neutral AI mention for Cost Plus Drugs, with no cautious or mixed tones recorded, suggesting AI engines frame it as a straightforward cost-saving resource rather than a clinically complex platform. Public sentiment broadly reflects praise for its pricing transparency model, which has been widely noted in consumer health coverage. Critics occasionally raise questions about catalog breadth and whether the platform covers the specific drugs a given patient needs.

Pricing is published drug by drug on the Cost Plus Drugs website using a transparent formula: the company's cost plus a fixed markup percentage plus a dispensing fee. Exact prices vary by medication and are not fixed in a subscription or membership tier. There is no membership fee required to purchase.